News
Significant gaps in arthritis subtype awareness among US adults underscore the need for improved health literacy and more ...
Patients with psoriatic arthritis who meet clinical criteria for minimal disease activity also tend to report good disease ...
1d
Everyday Health on MSN6 Reasons People Quit Their Psoriatic Arthritis Medication — and Why You Shouldn’tWhen psoriatic arthritis symptoms are under control, you may be tempted to stop taking medication. Here’s why that’s a bad idea.
Michaela Hagenhofer, General Manager, Commercial Operations at Johnson & Johnson Innovative Medicine, explains how J&J is ...
Racial and ethnic diversity is lacking in PsA clinical trials, with non-White participants remaining severely underrepresented.
Long-term treatment with ixekizumab does not increase the incidence of malignant neoplasms in patients with psoriasis, PsA, ...
It is indicated for various diseases including heumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic ...
4d
Everyday Health on MSN9 Tips for a Healthier Relationship With Your Psoriatic ArthritisPsA can be challenging, but these expert-approved tips for reframing how you think, talk, and feel about your condition can ...
21h
GlobalData on MSNLupin and Zentiva in licence and supply deal for Certolizumab PegolZentiva Group has entered into a licence and supply agreement with pharmaceutical company Lupin for the commercialisation of ...
Lupin and Zentiva partner to commercialize Certolizumab Pegol biosimilar globally, sharing profits and investing in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results